Hagström H - Search Results

1

Prevalence and risk factors of metabolic dysfunction-associated steatotic liver disease in south Central Uganda: A cross-sectional survey.

Enriquez R, Homsi M, Ssekubugu R, Nabukalu D, Zeebari Z, Marrone G, Gigante B, Chang LW, Reynolds SJ, Nalugoda F, Ekström AM, Hagström H, Nordenstedt H. Enriquez R, et al. Among authors: hagstrom h. Aliment Pharmacol Ther. 2024 May;59(9):1111-1121. doi: 10.1111/apt.17931. Epub 2024 Mar 8. Aliment Pharmacol Ther. 2024. PMID: 38459720

2

Editorial: severe outcomes are rare in pregnancy with autoimmune hepatitis.

Hagstrom H, Ludvigsson JF. Hagstrom H, et al. Aliment Pharmacol Ther. 2018 Nov;48(9):1017-1018. doi: 10.1111/apt.14957. Aliment Pharmacol Ther. 2018. PMID: 30318682 No abstract available.

3

Body mass index in early pregnancy and future risk of severe liver disease: a population-based cohort study.

Hagström H, Höijer J, Andreasson A, Bottai M, Johansson K, Ludvigsson JF, Stephansson O. Hagström H, et al. Aliment Pharmacol Ther. 2019 Mar;49(6):789-796. doi: 10.1111/apt.15162. Epub 2019 Feb 3. Aliment Pharmacol Ther. 2019. PMID: 30714185

4

Editorial: can urine-based metabolomics improve diagnosis of advanced fibrosis in NAFLD?

Hagström H. Hagström H. Aliment Pharmacol Ther. 2020 Jun;51(11):1204-1205. doi: 10.1111/apt.15744. Aliment Pharmacol Ther. 2020. PMID: 32424917 No abstract available.

5

Adaptation of the Charlson Comorbidity Index for Register-Based Research in Sweden.

Ludvigsson JF, Appelros P, Askling J, Byberg L, Carrero JJ, Ekström AM, Ekström M, Smedby KE, Hagström H, James S, Järvholm B, Michaelsson K, Pedersen NL, Sundelin H, Sundquist K, Sundström J. Ludvigsson JF, et al. Among authors: hagstrom h. Clin Epidemiol. 2021 Jan 12;13:21-41. doi: 10.2147/CLEP.S282475. eCollection 2021. Clin Epidemiol. 2021. PMID: 33469380 Free PMC article.

6

Improved prediction of 10-year risk of severe liver disease in the general population using commonly available biomarkers.

Hagström H, Yan J, Talbäck M, Andreasson A, Walldius G, Bottai M, Hammar N. Hagström H, et al. Aliment Pharmacol Ther. 2023 Feb;57(4):418-425. doi: 10.1111/apt.17374. Epub 2022 Dec 25. Aliment Pharmacol Ther. 2023. PMID: 36566508 Free PMC article.

7

Editorial: moving from the clinic towards population hepatology-authors' reply.

Hagström H, Hammar N. Hagström H, et al. Aliment Pharmacol Ther. 2023 Mar;57(6):728. doi: 10.1111/apt.17400. Aliment Pharmacol Ther. 2023. PMID: 36821746 No abstract available.

8

Letter: comment on Park et al - the association of non-alcoholic fatty liver disease between parents and adolescent children.

Hagström H, Ludvigsson JF. Hagström H, et al. Aliment Pharmacol Ther. 2023 Mar;57(6):737-738. doi: 10.1111/apt.17390. Aliment Pharmacol Ther. 2023. PMID: 36821758 No abstract available.

9

Misclassified Alcohol-related Liver Disease is Common in Presumed Metabolic Dysfunction-associated Steatotic Liver Disease and Highly Increases Risk for Future Cirrhosis.

Nasr P, Wester A, Ekstedt M, Strandberg R, Kechagias S, Shang Y, Widman L, Hagström H. Nasr P, et al. Among authors: hagstrom h. Clin Gastroenterol Hepatol. 2024 May;22(5):1048-1057.e2. doi: 10.1016/j.cgh.2024.01.006. Epub 2024 Jan 17. Clin Gastroenterol Hepatol. 2024. PMID: 38237695 Free article.

10

Evaluation of mucosal-associated invariant T-cells as a potential biomarker to predict infection risk in liver cirrhosis.

Bengtsson B, Maucourant C, Sandberg JK, Björkström NK, Hagström H. Bengtsson B, et al. Among authors: hagstrom h. PLoS One. 2024 May 1;19(5):e0294695. doi: 10.1371/journal.pone.0294695. eCollection 2024. PLoS One. 2024. PMID: 38691552 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

190 results

Search Page